FDA warns Proc­ter & Gam­ble over NyQuil la­bel's in­gre­di­ent list­ings

The FDA on Tues­day re­leased a warn­ing let­ter sent ear­li­er this month to the Ma­son, OH-based site of Proc­ter & Gam­ble Man­u­fac­tura, rais­ing ques­tions about the list of in­gre­di­ents on the la­bel and in the elec­tron­ic fil­ing.

The warn­ing says that for P&G’s over-the-counter Vicks Nyquil Se­vere Hot Rem­e­dy Cold and Flu Plus Con­ges­tion, there’s a “mis­matched” list of ac­tive in­gre­di­ents be­tween the la­bel­ing and the elec­tron­ic list­ing file. The list­ing file for the ac­tive in­gre­di­ents did not match the ac­tive in­gre­di­ents in the elec­tron­ic file.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER